Chlorin e6 as a Photosensitizer for Inducing Targeted Effects in Transscleral Photodynamic Therapy
Authors:
- Elena Vladislavovna SamkovichESElena Vladislavovna Samkovich
- Ernest Vitalievich BoikoEBErnest Vitalievich Boiko
- Irina Evgenievna PanovaIPIrina Evgenievna Panova
- Tatyana Georgievna GrishachevaTGTatyana Georgievna Grishacheva
- Sergey Leonidovich VorobyevSVSergey Leonidovich Vorobyev
- Elizaveta Sergeevna KalashnikovaEKElizaveta Sergeevna Kalashnikova
- Sergey Borisovich ShevchenkoSSSergey Borisovich Shevchenko
- Viktoria Gievna GvazavaVGViktoria Gievna Gvazava
- Elizaveta Antonovna MasianEMElizaveta Antonovna Masian
Open Access
- 24 August 2026
- journal article
- Published by Maad Rayan Publishing Company in Journal of lasers in medical sciences
- Vol. 17, e51515
Abstract
Introduction: This study aimed to evaluate the role of chlorin e6 in mediating targeted vascular injury during transscleral photodynamic therapy (TS-PDT) under controlled thermal conditions. Methods: Twenty eyes of ten rabbits were randomized into two groups. The TS-PDT group received intravenous chlorin e6 (2.5 mg/kg) followed by transscleral laser irradiation (660 nm, 0.17 W, 10 min.). The control group (TSLT) underwent identical laser exposure without a photosensitizer. Scleral temperature was monitored in real time using a thermal probe. On day 14, histological analysis assessed choroidal vascular thrombosis and stromal fibrosis using a semiquantitative scoring system. Retinal and scleral tissue damage was also evaluated. Results: The analysis accounting for inter-animal clustering revealed a significant association between chlorin e6 administration and choroidal vascular thrombosis (90% vs. 50%; adjusted OR=9.8, 95% CI: 1.4–68.9; P=0.021) and fibrosis (80% vs. 40%; adjusted OR=6.2, 95% CI: 1.1–35.0; P=0.039). Severity scores for thrombosis and fibrosis were also significantly higher in the TS-PDT group (P<0.001 for both). No significant differences in scleral temperature (P≥0.45) orretinal/scleral damage were observed. Conclusion: Vascular damage during TS-PDT is primarily photochemical, mediated by chlorin e6. No significant intergroupdifferences were observed in monitored scleral surface temperaturesunder these parameters, arguing against a major contribution from differential surface heating. The method demonstrates short-term structuralpreservation of surrounding ocular tissues, supporting itspotential as an organ-preserving treatment for intraocular tumors.Keywords
This publication has 34 references indexed in Scilit:
- Antitumor Effect of Photodynamic Therapy/Sonodynamic Therapy/Sono-Photodynamic Therapy of Chlorin e6 and Other ApplicationsMolecular Pharmaceutics, 2023
- Clinical development and potential of photothermal and photodynamic therapies for cancerNature Reviews Clinical Oncology, 2020
- Photodynamic therapy – mechanisms, photosensitizers and combinationsBiomedicine & Pharmacotherapy, 2018
- Photodynamic therapy (PDT) for malignant brain tumors – Where do we stand?Photodiagnosis and Photodynamic Therapy, 2015
- Functional Nanomaterials for Phototherapies of CancerChemical Reviews, 2014
- Stability enhanced polyelectrolyte-coated gold nanorod-photosensitizer complexes for high/low power density photodynamic therapyBiomaterials, 2014
- Photodynamic therapy of disseminated non-small cell lung carcinoma in a murine modelLasers in Surgery and Medicine, 2011
- Toward understanding the high PDT efficacy of chlorin e6–polyvinylpyrrolidone formulations: Photophysical and molecular aspects of photosensitizer–polymer interaction in vitroJournal of Photochemistry and Photobiology B: Biology, 2008
- Efficacy of antitumoral photodynamic therapy with hypericin: Relationship between biodistribution and photodynamic effects in the RIF-1 mouse tumor modelInternational Journal of Cancer, 2001
- Photodynamic therapy (PDT) of malignant tumorsCritical Reviews in Oncology/Hematology, 1984